Σημειώσεις επεισοδίου
OpenAI acquired Orchestra Bio on October 20, 2026 and folded it into Rosalind, its AI models and tools for life sciences research. This episode tests the thesis that the moat is owning the process, not the prompt: the 2.6 billion dollar figure is a 2016 estimate in 2013 dollars, the ten to fifteen year range is industry shorthand, and no verified evidence shows coordination causes most drug-development delays. What would prove the thesis is documented improvement in comparable programs, measured in decisions, delays, and evidence.Watch: https://youtu.be/9xQ3HiNCoq4X…
Ιστότοπος: podcasters.spotify.com

